|
|||
2008-10-28 15:52:51 CET 2008-10-28 15:53:51 CET REGULATED INFORMATION Sanitas AB - Notification on material eventOn the review of Sanitas AB strategic optionsThe Management Board and major shareholders of Sanitas AB (“Sanitas” or the"Company") initiated a strategic review in April 2008, to consider various strategic options available to the Company to enhance and realize shareholder value. Merrill Lynch International acted as financial adviser to the Company in the strategic review. This review has concluded that the Company's stand-alone operating plan represents the best way to enhance shareholder value for the medium term. This conclusion was reached based on a thorough analysis of the pharmaceutical industry, current macroeconomic conditions and available strategic transaction alternatives. On the basis of the conclusions of the strategic review and taking into account that Sanitas financial performance remains strong and the Company has a strong balance sheet as well as attractive niche positions in its key markets and good growth prospects, the Management Board of the Company on October 28, 2008 decided that the main focus of the Company in the medium term remains therefore its pipeline of new products and further growth in its current markets. Jurist Alina Nausedaite + 370 37 20 06 62 |
|||
|